Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
Karam, Chafic, Murai, Hiroyuki, Smilowski, Marek, Guglietta, Antonio, Utsugisawa, Kimiaki, Mantegazza, Renato, De Mey, Katrien, De Pue, Annelien, Mercelis, Rudolf, Daniyal, Lubna, Mannan, Shabber, Katzberg, Hans D., Siddiqi, Zaeem, Junkerová, Jana, Reguliova, Katerina, Jurajdova, Ivana, Vohanka, Stanislav, Havelkova, Katerina, Horak, Tomas, Horakova, Mageda, Kohler, Siegfried, Gerischer, Lea, Stascheit, Frauke, Autzen, Anne, Andersen, Henning, Salort-Campana, Emmanuelle, Delmont, Emilien, Tsiskaridze, Alexander, Rózsa, Csilla, Toth, Szilvia, Szabo, Gyorgyi, Szabo, Eniko, Campanella, Angela, Vanoli, Fiammetta, Puorro, Giorgia, Reia, Antonio, Antonini, Giovanni, Garibaldi, Matteo, Uzawa, Akiyuki, Sakuma, Kaoru, Yasuda, Manato, Onishi, Yosuke, Ishida, Sayaka, Watanabe, Genya, Takahashi, Masanori, Sugano, Erina, Kubota, Tomoya, Imai, Tomihiro, Suzuki, Mari, Mori, Ayako, Yamamoto, Daisuke, Ikeda, Kazuna, Hisahara, Shin, Minemoto, Kanako, Ido, Nobuhiro, Takematsu, Yuka, Shimizu, Mihiro, Nomura, Eiichi, Van Heur, Marjolein, Tannemaat, Martijn, Ruiter, Annabel, Halas, Marek, Szczudlik, Andrzej, Pinkosz, Marta, Frasinska, Monika, Urtaeva, Lubov, Romanova, Tatiana, Lapochka, Elena, Korobko, Denis, Vergunova, Ilona, Bulatova, Ekaterina, Basta, Ivana, Akhter, Salma, Malekniazi, Ali, Darki, Leila, Cannon, Victoria, Chopra, Manisha, Traub, Rebecca, Habib, Ali, Goyal, Namita, Jones, Sarah, Wagoner, Mary, Benzel, Cindy, Jackson, Carlayne, Dimitrova, Diana, Chahin, Nizar, Levine, Todd, Lisak, Robert, Jia, Kelly, Roath, Katherine, Barohn, Richard, Dimachkie, Mazen, Li, Yuebing, Caristo, Irys, Hastings, Debbie, Muppidi, Srikanth, Welsh, Lesly, Quraishi, Zubair, Berger, Alan, Frishberg, Benjamin
Published in Lancet neurology (01.07.2021)
Published in Lancet neurology (01.07.2021)
Get full text
Journal Article